1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. interferon beta 1a, methotrexate, methylprednisolone - Demyelinating Disorders, Multiple Sclerosis | Phase 4 | Withdrawn | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | 2002-05-01 | 2018-04-12 |
Demyelinating Diseases (1) · Multiple Sclerosis (1) · Neuritis (1) · Optic Neuritis (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Eye Diseases (1) · Immune System Diseases (1) · Infections (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Neuromuscular Diseases (1) · Optic Nerve Diseases (1) · Peripheral Nervous System Diseases (1) · Spinal Cord Diseases (1)
Interferon beta-1a (1) · Methotrexate (1) · Methylprednisolone (1)
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute (1)
United States (1)